Clinical efficacy of sunitinib as post-operative adjuvant therapy in patients with high-risk renal cell carcinoma

被引：0
|
作者：
Zhang, Xu
Yuan, Jianlin
Wang, Liang
Chen, Lijun
Pan, Jinhong
Ye, Linyang
Xiao, Xuren
Qiu, Jianhong
Zhang, Keqin
Ye, Gang
机构：
[1] Peoples Liberat Army, Gen Hosp, Beijing, Peoples R China
[2] Fourth Mil Med Univ, Xijin Hosp, Xian 710032, Peoples R China
[3] Univ Chengdu, Mil Gen Hosp, Chengdu, Peoples R China
[4] PLA, Hosp 307, Beijing, Peoples R China
[5] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China
[6] PLA, Hosp 304, Beijing, Peoples R China
[7] Armed Police Forces, Gen Hosp, Beijing, Peoples R China
[8] PLA, Bethune Int Peace Hosp, Shijiazhuang, Peoples R China
[9] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China
[10] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15547
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CLINICAL EFFICACY OF SUNITINIB AS POST-OPERATIVE ADJUVANT THERAPY IN PATIENTS WITH HIGH-RISK RENAL CELL CARCINOMA
    Zhang, X.
    Yuan, J. Y.
    Wang, L.
    Chen, L.
    Pan, J.
    Ye, L.
    Xiao, X.
    Qiu, J.
    Zhang, K.
    Ye, G.
    ANNALS OF ONCOLOGY, 2012, 23 : 281 - 281
  • [2] The significance of post-operative local radiation therapy in high-risk patients with localised renal cell carcinoma
    Mahn, M
    Panse, C
    Lemnitzer, H
    Stolzenburg, JU
    Hildebrandt, G
    Kortmann, RD
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 114 - 114
  • [3] Adjuvant therapy for high-risk renal cell carcinoma patients
    Kunkle D.A.
    Haas N.B.
    Uzzo R.G.
    Current Urology Reports, 2007, 8 (1) : 19 - 30
  • [4] Are We Ready for Adjuvant Sunitinib in High-risk Renal Cell Carcinoma?
    Casuscelli, Jozefina
    Hsieh, James J.
    EUROPEAN UROLOGY, 2018, 73 (01) : 69 - 70
  • [5] Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
    Ravaud, A.
    Motzer, R. J.
    Pandha, H. S.
    George, D. J.
    Pantuck, A. J.
    Patel, A.
    Chang, Y. -H.
    Escudier, B.
    Donskov, F.
    Magheli, A.
    Carteni, G.
    Laguerre, B.
    Tomczak, P.
    Breza, J.
    Gerletti, P.
    Lechuga, M.
    Lin, X.
    Martini, J. -F.
    Ramaswamy, K.
    Casey, M.
    Staehler, M.
    Patard, J. -J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (23): : 2246 - 2254
  • [6] Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma
    Wood, Erika
    Donin, Nicholas
    Shuch, Brian
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (03) : 345 - +
  • [7] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma after Nephrectomy
    Klatte, Tobias
    EUROPEAN UROLOGY, 2017, 71 (05) : 835 - 836
  • [8] Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Struss, Werner J.
    Black, Peter C.
    UROLOGY, 2017, 105 : 13 - 13
  • [9] Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Ravaud, A.
    Motzer, R. J.
    Pandha, H. S.
    UROLOGY, 2017, 105 : 13 - 13
  • [10] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Salmasi, Amirali
    Faiena, Izak
    Drakaki, Alexandra
    Pantuck, Allan J.
    EUROPEAN UROLOGY, 2018, 74 (01) : 119 - 121
12345